Top Brand
Salt CompositionOur Recommendation
Sutinat 50 Capsule
152+ trust this
WHO GMP Certified
152+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Kidney cancer / Gastrointestinal stromal tumour
Customers also bought
More About Sutinat
Benefits
In Kidney cancer Sutinat 50 Capsule is used to treat kidney cancer and its associated symptoms such as blood in the urine, unexplained low back pain or weight loss, fatigue, loss of appetite, etc. It stops cancer growth and prevents multiplication of cancer cells. This restricts the advancement of cancer to other unaffected regions. You need to follow your doctor?s instructions very carefully to recover. In Gastrointestinal stromal tumour A gastrointestinal stromal tumor (GIST) is a type of tumor that occurs most commonly in the stomach or small intestine. The tumors develop into the specialized cells called interstitial cells of Cajal (ICCs). Sutinat 50 Capsule helps to kill the cancer cells and also stops their further growth and spread. Follow your doctor?s instructions carefully to get the most benefit.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Sutinat 50 Capsule can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Sutinat 50 Capsule is an anti-cancer medication. It works by binding and blocking certain cell surface protein (tyrosine kinase) responsible for the propagation of cancer growth. It also restricts the growth of new blood vessels within the tumor. This is how it prevents the proliferation of malignant cancers.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Sutinat 50 Capsule . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Sutinat 50 Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Not Safe: Sutinat 50 Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Not Safe: Sutinat 50 Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Safe when prescribed by an expert: Sutinat 50 Capsule is safe to use in patients with kidney disease. No dose adjustment of Sutinat 50 Capsule is recommended.
Caution Advised: Sutinat 50 Capsule should be used with caution in patients with severe liver disease. Dose adjustment of Sutinat 50 Capsule may be needed. Doctor consultation is advised. Limited information is available on the use of Sutinat 50 Capsule in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
What if I forget to take it?
If you forget a dose of Sutinat 50 Capsule , simply continue with your regular schedule and do not take a double dose.
Manufacturer Address
Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India
References
Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1740
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 955
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1304
Sunitinib malate (25 Oct. 2023)
Sunitinib malate. Sandwich, Kent: Pfizer Limited; 2006 (27 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (27 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.